The Trend Catcher | NVDA +7% on Earnings Boost; FROG (Rating 96) Breaks Out +8%; Computer Sftwr-Medical Jumps 13%+

NVIDIA Corporation
JFrog Ltd.
NASDAQ
S&P 500 index
Dow Jones Industrial Average

NVIDIA Corporation

NVDA

0.00

JFrog Ltd.

FROG

0.00

NASDAQ

IXIC

0.00

S&P 500 index

SPX

0.00

Dow Jones Industrial Average

DJI

0.00

Subscribe to "The Trend Catcher Topic," tracking hottest sectors & technical breakouts in real time daily, accompanying you every US stock trading day.


1. Leader industry as of 5:50 pm

NamePrice % ChgInd Group RankInd Grp Rnk 3 Mo Ago% Chg YTDInd Mkt Val (bil)
Computer Sftwr-Medical13.51%813910.5%60.9
Computer Sftwr-Security11.68%151983.8%751.6
Elec-Semiconductor Fables5.29%622330.0%8,494.1
Finance - Crypto/Blockchain4.82%533613.1%217.3
Computer Sftwr-Design4.13%4286-7.2%441.8

Computer Sftwr-Medical related stocks: Veeva Systems(VEEV.US) , Waystar Holding Corp.(WAY.US) , Doximity, Inc. Class A(DOCS.US) , American Well Corporation Class A(AMWL.US) , Simulations Plus, Inc.(SLP.US) , Weave Communications, Inc.(WEAV.US) , HeartFlow, Inc.(HTFL.US) 

Computer Sftwr-Security related stocks: Fortinet, Inc.(FTNT.US) , Palo Alto Networks, Inc.(PANW.US) , TENABLE HOLDINGS, INC.(TENB.US) , Qualys, Inc.(QLYS.US) , Okta(OKTA.US) , Rubrik(RBRK.US) , Gen Digital Inc.(GEN.US) 

Quick Summary and Outlook

The NASDAQ(IXIC.US)  was higher on Thursday as the latest earnings reports from NVIDIA Corporation(NVDA.US)  and other well-known technology companies boosted sentiment.
The tech-heavy index rose 1.1%, while the S&P 500 index(SPX.US)  advanced 0.5%. The Dow Jones Industrial Average(DJI.US)  traded around the flatline.
NVIDIA Corporation(NVDA.US)  shares jumped 7% after it reported earnings and forecast strong revenue growth. Notably, the chipmaker is projected to see revenue growth of 70% in fiscal 2028, far higher than the 44% that analysts surveyed by LSEG expected. Its revenue for the fiscal second quarter more than doubled.


2.  Breaking Out Today as of 5:45 pm

SymbolComp RatingIndustry NameCurrent PricePrice % ChgMarket Cap (mil)
JFrog Ltd.(FROG.US) 98Comp Sftwr - Enterprise100.878.70%11,442.4

3. Near Breakouts as of 5:50 pm

SymbolComp RatingIndustry NameCurrent PricePrice % ChgMarket Cap (mil)
Exelixis, Inc.(EXEL.US) 99Medical - Profitable Biotech55.36-1.32%13,900.8
Moody's Corporation(MCO.US) 98Financial Svcs-Specialty514.580.20%89,120.1
BlackRock, Inc.(BLK.US) 89Finance-Investment Mgmt1,176.810.31%190,618.7
UBS Group AG(UBS.US) 89Banks-Money Center54.33-0.36%164,879.5
FedEx Corporation(FDX.US) 86Transport-Air Freight333.86-0.69%79,518.9
Kymera Therapeutics, Inc.(KYMR.US) 86Medical - Development Biotech122.88-2.13%10,439.6
Equinix, Inc.(EQIX.US) 79REITs1,088.860.86%105,526.9
Arcus Biosciences, Inc.(RCUS.US) 66Medical - Revenue Biotech30.64-0.37%3,916.8

 

Subscribe to The Trend Catcher Topic / The Value Anchor Topic —unlock the full historical archive and never miss a weekly pick again.

More of Our Investment Philosophy>>


Notable Stock Movers as of 5:50 pm

NVIDIA Corporation(NVDA.US)  reported better-than-expected second-quarter financial results and issued a strong revenue forecast for the current quarter, after the closing bell on Wednesday. The stock is up over 7%.

Nvidia reported second-quarter revenue of $96.22 billion, up 106% year-over-year. The revenue total beat a Street consensus estimate of $92.18 billion, according to data from Benzinga Pro.

Propanc Biopharma Inc (Propanc Biopharma(PPCB.US) ) shares shot up 169% after the company announced preclinical and early translational data for its lead candidate PRP in pancreatic ductal adenocarcinoma.
Shares of VolitionRX Ltd (VolitionRX Ltd(VNRX.US) ) got a boost, surging 80% after the diagnostics company reported a 112% year-over-year revenue surge in the first half of 2026, reaching $1.4 million as it expanded its clinical and commercial operations.
Mint Incorporation Ltd (Mint(MIMI.US) ) shares were also up, gaining 49% after dipping over 6% on Wednesday.


Disclaimer: The content is provided as general information only and should not be taken as investment advice. All the contents shall not be taken as a recommendation to buy or sell any security or financial instruments. Any action you take resulting from information, analysis, or commentary on this article is your responsibility. Please consult your investment advisor before making any investments.